Determination of ulifloxacin, the active metabolite of prulifloxacin, in human plasma by a 96-well format solid-phase extraction and capillary zone electrophoresis

Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences

Volumn 872, Issue 1-2, 2008, Pages 172-176

  Zhang, Lingli ^a,b   Wen, Jun ^a,b   Pan, Yaju ^a,b   Li, Zhen ^c   Fan, Guorong ^a,b   Wu, Yutian ^a,b  

^a SECOND MILITARY MEDICAL UNIVERSITY   (China)

^b SHANGHAI KEY LABORATORY FOR PHARMACEUTICAL METABOLITE RESEARCH   (China)

^c SECOND MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

96 Well format SPE; CZE; Prulifloxacin; Ulifloxacin

Indexed keywords

CAPILLARY ELECTROPHORESIS; ELECTROCHEMISTRY; ELECTROPHORESIS; FUSED SILICA; ISOMERS; METABOLITES; METHANOL; OFFSHORE OIL WELL PRODUCTION; PHOSPHORIC ACID; PLASMA (HUMAN); PLASMA STABILITY; PLASMAS; SEPARATION; SILICA; SILICATE MINERALS; SILICON COMPOUNDS; STANDARDS; WELLS;

96-WELL; 96-WELL FORMAT SPE; ACID WATERS; ANALYTES; APPLIED VOLTAGES; BORATE BUFFERS; CALIBRATION GRAPHS; CAPILLARY ZONE ELECTROPHORESIS; CZE; DETECTION WAVELENGTHS; EXTRACTION RECOVERY; FUSED-SILICA CAPILLARIES; HUMAN PLASMAS; INTERNAL STANDARD; LOMEFLOXACIN; LOWER LIMIT OF QUANTIFICATION; LOWER LIMIT OF QUANTITATION; ORAL ADMINISTRATION; PHARMACOKINETIC STUDIES; PLASMA SAMPLES; PRE-CONCENTRATION; PRULIFLOXACIN; SOLID-PHASE EXTRACTION; ULIFLOXACIN;

EXTRACTION;

AMMONIA; METHANOL; PRULIFLOXACIN; ULIFLOXACIN; UNCLASSIFIED DRUG;

ACCURACY; ARTICLE; CALIBRATION; CAPILLARY ZONE ELECTROPHORESIS; DRUG DETERMINATION; DRUG FORMULATION; HUMAN; MALE; NORMAL HUMAN; PRIORITY JOURNAL; SOLID PHASE EXTRACTION;

ANTI-BACTERIAL AGENTS; DIOXOLANES; ELECTROPHORESIS, CAPILLARY; FLUOROQUINOLONES; HUMANS; PIPERAZINES; REFERENCE STANDARDS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; SPECTROPHOTOMETRY, ULTRAVIOLET;

EID: 49849099370     PISSN: 15700232     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jchromb.2008.07.033     Document Type: Article

References (21)

1. Ozaki M., Matsuda M., Tomii Y., Kimura K., Segawa J., Kitano M., Kise M., Shibata K., Otsuki M., and Nishino T. Antimicrob. Agents Chemother. 35 (1991) 2496
2. Yoshida Y., and Mitsuhashi S. Antimicrob. Agents Chemother. 37 (1993) 793
3. Tougou K., Nakamura A., Watanabe S., Okuyama Y., and Morino A. Drug Metab. Dispos. 26 (1998) 355
4. Keam S.J., and Perry C.M. Drugs 64 (2004) 2221
5. Nakashima M., Uematsu T., Kosuge K., Okuyama Y., Morino A., Ozaki M., and Takebe Y. J. Clin. Pharmacol. 34 (1994) 930
6. Matera M.G. Pulm. Pharmacol. Ther. 19 (2006) 20
7. Okuyama Y., Momota K., and Morino A. Arzneimittelforschung 47 (1997) 276
8. Tanimura H., Ishimoto K., Murakami K., Uchiyama K., and Iwakura S. Drugs 49 (1995) 337
9. Picollo R., Brion N., Gualano V., Millérioux L., Marchetti M., Rosignoli M.T., and Dionisio P. Arzneimittelforschung 53 (2003) 201
10. Wen J., Zhu Z.Y., Hong Z.Y., Wu Y.T., Fei Y., Lin M., Fan G.R., and Wu Y.T. Chromatographia 66 (2007) 37
11. Guo L.X., Qi M.L., Jin X., Wang P., and Zhao H.Q. J. Chromatogr. B 832 (2006) 280
12. Cheng C.L., Fu C.H., and Chou C.H. J. Chromatogr. B 856 (2007) 381
13. Lara F.J., Garcia-Campana A.M., Ales-Barrero F., and Bosque-Sendra J.M. Electrophoresis 29 (2008) 2117
14. Lara F.J., Garcia-Campana A.M., Ales-Barrero F., Bosque-Sendra J.M., and Garcia-Ayuso L.E. Anal. Chem. 78 (2006) 7665
15. Juan-Garcia A., Front G., and Pico Y. Electroohoresis 27 (2006) 2240
16. Barron D., Jimenez-Lozano E., and Bailac S. J. Barbosa Anal. Chim. Acta 477 (2003) 21
17. Venn R.F., Merson J., Cole S., and Macrae P. J. Chromatogr. B 817 (2005) 77
18. Apostolou C., Dotsikas Y., Kousooulos C., Tsatsou G., Colocouri F., Soumelas G.S., and Loukas Y.L. J. Pharm. Biomed. Anal. 43 (2007) 1151
19. Rose M.J., Fernandez-Metzler C., Johns B.A., Sitko G.R., Cook J.J., and Yergey J. J. Pharm. Biomed. Anal. 38 (2005) 695
20. Yeh L.T., and Borges V. J. Chromatogr. B 852 (2007) 465
21. Guidance for industry, bioanalytical method validation, US Department of Health and Human Services, Food and Drug Adiministration, Center for Drug Evaluation and Research (CDER), Center for Veternary Medicine (CVM), May 2001, available at http://www.fda.gov/cder/guidance/4252fnl.htm.